| 000 | 01764 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518023616.0 | ||
| 264 | 0 | _c20191218 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1545-5017 | ||
| 024 | 7 |
_a10.1002/pbc.27674 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLe Rouzic, Marie-Amelyne | |
| 245 | 0 | 0 |
_aAgreement between clinicoradiological signs at diagnosis and radiohistological analysis after neoadjuvant chemotherapy of suspected Wilms tumor rupture: Consequences on therapeutic choices. _h[electronic resource] |
| 260 |
_bPediatric blood & cancer _c06 2019 |
||
| 300 |
_ae27674 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aChemotherapy, Adjuvant _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoadjuvant Therapy _xadverse effects |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRupture, Spontaneous _xchemically induced |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTomography, X-Ray Computed _xmethods |
| 650 | 0 | 4 | _aTumor Burden |
| 650 | 0 | 4 |
_aWilms Tumor _xdrug therapy |
| 700 | 1 | _aMansuy, Ludovic | |
| 700 | 1 | _aGalloy, Marie-Agnès | |
| 700 | 1 | _aChampigneulle, Jacqueline | |
| 700 | 1 | _aBernier, Valérie | |
| 700 | 1 | _aChastagner, Pascal | |
| 773 | 0 |
_tPediatric blood & cancer _gvol. 66 _gno. 6 _gp. e27674 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/pbc.27674 _zAvailable from publisher's website |
| 999 |
_c29382122 _d29382122 |
||